Episode 151: Breaking Through at CVRx
Show: Medtech Talk
From senior leadership positions at GE Healthcare and Medtronic to board chairman at MDIC and AdvaMed, Nadim is a seasoned medtech executive who is passionate about the industry. Now at the helm of CVRx, a company developing a pioneering technology for treating high blood pressure and heart failure, Nadim shares his experience navigating the FDA’s first Breakthrough Device Designation, working with CMS on reimbursement coding, and building CVRx’s strong leadership team
More From Current Show
“Assistive” devices are often bulky, but not the one Jeremiah Robison, founder and CEO of Cionic, has developed....
Listen Now 
At this year’s Medtech MVP, a panel of industry experts explored how robotics are changing healthcare beyond the...
Listen Now 
A discectomy can feel like instant relief until the pain comes back, and the “small” hole in the...
Listen Now 
Brian Webster, President and CEO of Kestra Medical Technologies (Nasdaq: KMTS), joins Medtech Talk to discuss his 30-year...
Listen Now 
How do you approach growing and investing? Quentin Blackford, president and CEO of iRhythm Technologies, joins Medtech Talk...
Listen Now 
How do you evaluate investments and risks? Kate Garret, managing partner at Sonder, and Deborah Kilpatrick, partner at...
Listen Now 
Meeting the right people can completely change the trajectory of one’s career. In this episode of Medtech Talk,...
Listen Now 
The data gap in women’s health has always been a major issue and challenge. Ridhi Tariyal, CEO and...
Listen Now Related Episodes
What if you can be successful, needed, productive, and admired, and still feel like you don't matter? That's...
Listen Now 
In this episode, we explore the technology, innovation and clinical expertise shaping the future of cardiac and neuro...
Listen Now 
What if you're working harder and harder—but you're still moving in the wrong direction? Alec Litowitz learned this...
Listen Now 
Why What Matters Most Is Rarely the Loudest What if the things getting the most attention in your...
Listen Now 
As demand for donor hearts continues to outpace supply, donation after circulatory death (DCD) is helping expand access...
Listen Now 
